Lymphangioma
📧 Sign up to get email alerts when something new happens for Lymphangioma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-17Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Everolimus in Patients With Teratment-refractory Vascular Anomalies [Phase 2]
Phase 2 clinical trial evaluating the efficacy and safety of everolimus in patients with treatment-refractory vascular anomalies. The study …
-
CLINICAL_TRIALS research · 2026-02-19Clinical Trial Update: A Trial of Targeted Therapies for Patients With Slow-Flow or Fast-Flow Vascular Malformations [Phase 2]
Phase 2 clinical trial update evaluating targeted therapies for slow-flow and fast-flow vascular malformations; the study is currently recru…
-
CLINICAL_TRIALS trial_result · 2025-04-24Clinical Trial Update: Bleomycin as an Effective and Curative Adjunct Therapy for Lymphangioma
Completed clinical trial from National Children's Hospital, Vietnam evaluating bleomycin as an adjunct therapy for lymphangioma reports favo…
-
CLINICAL_TRIALS research · 2025-03-25Clinical Trial Update: Institution of an Italian Registry and Biobank for Biological Sample Collection [NA]
An Italian registry and biobank are being established to collect biological samples for lymphatic malformation and related lymphatic conditi…
-
CLINICAL_TRIALS trial_result · 2014-06-12Clinical Trial Update: A Study to Evaluate Sildenafil for the Treatment of Lymphatic Malformations [Phase 1, Phase 2]
Results from a Phase 1/2 study evaluating sildenafil for the treatment of lymphatic malformations (lymphangioma) are reported; the trial con…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.